Peptide hydrolysates from Mexican edible worms showed potent ACE inhibition — the red worm peptides outperformed the blood pressure drug enalapril by sixfold in lab tests.
6x more potent ACE inhibition than enalaprilRed worm peptides achieved an IC50 of 0.017 μg/mL for ACE inhibition, compared to 0.11 μg/mL for the prescription blood pressure drug enalapril — in laboratory assays.
What the researchers found
Sequential hydrolysis with pepsin and trypsin (PTH) produced the most bioactive peptides, showing ABTS radical inhibition above 90% and DPPH radical scavenging of 75–85%. ACE inhibitory activity was exceptional: red worm hydrolysate (RWPH) achieved an IC50 of 0.017 μg/mL — about sixfold more potent than enalapril (IC50 = 0.11 μg/mL). White worm hydrolysate (WWPH) had an IC50 of 0.35 μg/mL.
SDS-PAGE analysis revealed the active peptides were low molecular weight (<10 kDa, primarily 5–9 kDa). Red worm peptides showed low Hill coefficients, indicating gradual and sustained interaction with the ACE enzyme rather than an abrupt on-off binding — a pharmacologically favorable property.
Why it matters
Edible insects are increasingly recognized as a sustainable protein source that could help feed a growing global population. Finding that these traditional food sources also contain peptides with pharmaceutical-level bioactivity adds significant value. If these findings translate to human consumption, edible insect products could serve dual roles as nutrition and functional food for cardiovascular health — particularly relevant in populations where access to prescription blood pressure medications is limited.
How the study worked
Proteins were extracted from two edible Mexican insect species (Aegiale hesperiaris and Comadia redtenbacheri) and hydrolyzed using either pepsin alone (PH) or pepsin followed by trypsin (PTH). Hydrolysates were characterized by SDS-PAGE for molecular weight distribution. Antioxidant activity was measured using ABTS and DPPH assays. ACE inhibitory activity was determined by IC50 values and Hill coefficient analysis. Results were compared against the pharmaceutical ACE inhibitor enalapril.
What this study cannot tell us
All bioactivity testing was performed in vitro (test tube assays), not in living organisms or humans. The exceptional ACE inhibition IC50 values may not translate to blood pressure-lowering effects after oral consumption, as the peptides would need to survive digestion and reach the bloodstream intact. The comparison with enalapril is based on enzyme inhibition assays, not clinical blood pressure outcomes — enalapril has decades of proven clinical efficacy. Whether regular consumption of these insects would provide meaningful cardiovascular benefits is entirely unknown.
How to read the evidence
This is an in vitro food science study measuring enzyme inhibition and antioxidant activity in test tube assays. While the results are striking, no animal or human data supports health claims. The evidence is preliminary and the comparison with enalapril applies only to enzyme inhibition, not clinical outcomes.
When this study was published
Published in 2025, this is a very recent study contributing to the growing body of research on edible insect bioactive peptides.
The bigger picture
The search for food-derived bioactive peptides with health benefits is a rapidly growing field at the intersection of food science and nutraceuticals. Edible insects represent an emerging frontier — they're sustainable, protein-rich, and culturally established in many parts of the world. This study demonstrates that insect proteins can yield peptides with bioactivity exceeding that of established drugs in laboratory assays, adding to the case for insects as functional food ingredients alongside traditional sources like milk, fish, and soybeans.
Questions still open
- Would these insect-derived peptides survive human digestion and retain their ACE-inhibiting activity after oral consumption?
- Could edible insect products be developed as functional foods with clinically validated blood pressure-lowering effects?
- What specific peptide sequences are responsible for the exceptional ACE inhibition of the red worm hydrolysate?
Common questions
Could eating edible insects lower blood pressure?
What makes insect peptides different from regular insect protein?
Read the original research
Production of Protein Hydrolysates with Antioxidant and Antihypertensive Activity from Edible Larvae of Aegiale hesperiaris and Comadia redtenbacheri.
Foods (Basel, Switzerland), 14(12)
Citation
Garrido-Ortiz, Eduardo R; Morales-Camacho, Jocksan I. (2025). Production of Protein Hydrolysates with Antioxidant and Antihypertensive Activity from Edible Larvae of Aegiale hesperiaris and Comadia redtenbacheri.. Foods (Basel, Switzerland), 14(12). https://doi.org/10.3390/foods14122124